South Texas launches world’s only mobile cell therapy collection vehicle

The bus is designed to expand access to lifesaving, next-generation treatments across nearly 70,000 square miles of ...
Nasdaq

BioLineRx Announces FDA Approval of APHEXDAâ„¢ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent ...

- APHEXDA is the first innovation in stem cell mobilization for multiple myeloma to be approved in the U.S. in a decade - - One dosage of APHEXDA plus filgrastim enabled a majority of patients to ...
Healio

FDA approves Aphexda for mobilization of stem cells before transplant in multiple myeloma

Please provide your email address to receive an email when new articles are posted on . The FDA approved motixafortide combined with filgrastim for mobilization of hematopoietic stem cells into ...
Cure Today

Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...
Hosted on MSN

Exicure stock soars 40% after stem cell drug helps most patients hit phase 2 goal — traders call it 'cheap' at current levels

・Phase 2 data showed rapid increases in CD34+ stem cells, allowing same-day dosing and collection. ・Daratumumab-treated patients, who often struggle with mobilization, also achieved strong collection ...
Hosted on MSN

Life-saving stem cell centre welcomes first donors

The UK's first stem cell collection centre strictly dedicated to transplants has started welcoming donors. The Anthony Nolan Cell Collection Centre, based at Nottingham's Queen's Medical Centre (QMC), ...
Mena FN

Exicure Announces Publication In Annals Of Hematology Highlighting Rapid Stem Cell Mobilization With Burixafor In Patients With Multiple Myeloma And Lymphoma Undergoing Transplant

(MENAFN- GlobeNewsWire - Nasdaq) Phase 2 data demonstrate differentiated CXCR4 inhibition kinetics enabling same-day cell collection, with rapid lymphocyte mobilization supporting potential ...
MarketWatch

Gift of Life Marrow Registry to Help More Patients with Expanded Stem Cell Collection Center and Therapy Laboratory at Boca Raton Headquarters

The MarketWatch News Department was not involved in the creation of this content. BOCA RATON, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Gift of Life Marrow Registry marked a major milestone with a ...
Nature

Stem cell-derived therapies

All cell types found in the body are derived from stem cells. However, genetic mutations can impact the ability of stem cells to develop into fully functional cells. Also, as the body ages, the number ...
ascopubs.org

Effect of lenalidomide induction therapy on peripheral blood stem cell collection in patients undergoing autologous stem cell transplant for multiple myeloma.

Dose-intensive cyclophosphamide, etoposide, cisplatin reinduction for relapsed/refractory aggressive non-Hodgkin lymphoma (r/r-aNHL). The comparison of up-front autologous peripheral stem cell ...
The American Journal of Managed Care

FDA Approves Motixafortide Plus Filgrastim for Stem Cell Mobilization in Multiple Myeloma

The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma. The FDA approved motixafortide ...